Hydroxycarbamide: A treatment for lichen sclerosus? [9]

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 622-

  Tomson, N ^a   Sterling, J C ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; HYDROXYUREA; RIBONUCLEOTIDE REDUCTASE; TRIMOVATE; UNCLASSIFIED DRUG;

AGED; ANTINEOPLASTIC ACTIVITY; CASE REPORT; CELL CULTURE; CELLULAR IMMUNITY; CHRONIC MYELOID LEUKEMIA; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG INHIBITION; FEMALE; HOSPITAL DEPARTMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOHISTOCHEMISTRY; LETTER; LICHEN SCLEROSUS ET ATROPHICUS; MALAISE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PURPURA; SICKLE CELL ANEMIA; TELANGIECTASIA; THROMBOCYTOSIS; VULVA PRURITUS;

AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; HYDROXYUREA; POLYCYTHEMIA; TREATMENT OUTCOME; VULVAR LICHEN SCLEROSUS;

EID: 34547857024     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07991.x     Document Type: Letter

References (4)

1. Chan I, Oyama N, Neill SM et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol 2004 29 : 499 504.
2. Farrell AM, Dean D, Millard PR et al. Cytokine alterations in lichen sclerosus: an immunohistochemical study. Br J Dermatol 2006 155 : 931 40.
3. Weinberg A. In vitro hydroxyurea decreases Th1 cell-mediated immunity. Clin Diagn Lab Immunol 2001 8 : 702 5.
4. Silver RT. Treatment of polycythemia vera. Semin Thromb Hemost 2006 32 : 437 42.